Roche
GT Molecular Awarded CDC Contract to Develop dPCR Wastewater Assays
The newest contract has been expanded to include 30 targets and an additional digital PCR system, and could be worth up to $1.7 million.
Massive Bio, Foundation Medicine Partner to Improve Oncology Clinical Trial Enrollment
The companies will develop integrated solutions that use shared data and AI analytics focused on patient matching to clinical trials.
Foundation Medicine, Syndax Pharmaceuticals Partner to Develop CDx for AML Treatment
The companion diagnostic assay, for a drug under development by Syndax, will identify acute myeloid leukemia patients with an NPM1 mutation.
Roche Invests RMB 3B to Expand Chinese Diagnostics Facility
The production facility focuses on the manufacturing of diagnostic products mainly for China and parts of Asia-Pacific.
At the ADLM annual meeting, firms said they see game-changing opportunities for platforms that provide the right combination of clinical utility and convenience.
Jul 24, 2024
May 22, 2024
May 22, 2024
May 1, 2024